Highlights
• Strong economics with a base case pre-tax net present value of US$1.571 billion and an internal rate of
return of 53%.
• Low capital cost requirement of US$400 million (excluding contingency) with a payback period within the
first 3 years of production.
• Low operating cash costs of US$10.09 per kg Free on Board "FOB" for the first 5 years of production
with an average cost of $US11.05 per kg over 25 years.
• Annual average revenues of US$361 million at 10,000 tonne equivalent rare earth oxide production.
• Scoping study mine plans based solely on the Indicated and Measured portions of the Mineral Resource.
• Significant opportunity and available resource to upscale production to 40,000 tonnes per annum and
extend the mine life, as the base case scoping study mine plan exploits less than 10% of the total
Mineral Resource.
• The highest grade large scale rare earth deposit in Africa and the fifth largest deposit outside of China.
• Mineralisation is not radioactive and has the lowest levels of uranium (18ppm) and thorium (43ppm) of
any major rare earth deposit.
• Beneficiation and metallurgical process proven in laboratory test work with pilot plant work underway.
• Relatively simple metallurgical process utilising sulphuric acid leaching with no inherently troublesome
acid cracking or baking requirements.
• On target to begin production in Q1 2016.
- Forums
- ASX - By Stock
- scoping study
Highlights• Strong economics with a base case pre-tax net...
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PEK (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.5¢ |
Change
-0.005(2.63%) |
Mkt cap ! $49.28M |
Open | High | Low | Value | Volume |
18.5¢ | 18.5¢ | 18.5¢ | $5.663K | 30.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 74391 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 33315 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 74391 | 0.185 |
8 | 350777 | 0.180 |
5 | 116924 | 0.175 |
9 | 236218 | 0.170 |
2 | 12500 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 33315 | 3 |
0.225 | 13300 | 1 |
0.230 | 5764 | 1 |
0.240 | 20000 | 1 |
0.250 | 70834 | 3 |
Last trade - 15.00pm 10/10/2024 (20 minute delay) ? |
Featured News
PEK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online